Display options
Cite
Hukema RK, Riemslagh FW, Melhem S, et al. Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD. Acta Neuropathol Commun. 2016;4(1):129doi: 10.1186/s40478-016-0401-9.
Hukema, R. K., Riemslagh, F. W., Melhem, S., van der Linde, H. C., Severijnen, L. W., Edbauer, D., Maas, A., Charlet-Berguerand, N., Willemsen, R., & van Swieten, J. C. (2016). Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD. Acta neuropathologica communications, 4(1), 129. https://doi.org/10.1186/s40478-016-0401-9
Hukema, Renate K, et al. "Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD." Acta neuropathologica communications vol. 4,1 (2016): 129. doi: https://doi.org/10.1186/s40478-016-0401-9
Hukema RK, Riemslagh FW, Melhem S, van der Linde HC, Severijnen LW, Edbauer D, Maas A, Charlet-Berguerand N, Willemsen R, van Swieten JC. Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD. Acta Neuropathol Commun. 2016 Dec 09;4(1):129. doi: 10.1186/s40478-016-0401-9. PMID: 27938413; PMCID: PMC5148842.
Copy Download .nbib Format: NLM
Share it on

Acta Neuropathol Commun. 2016 Dec 09;4(1):129. doi: 10.1186/s40478-016-0401-9.

Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD.

Acta neuropathologica communications

Renate K Hukema, Fréderike W Riemslagh, Shamiram Melhem, Herma C van der Linde, Lies-Anne W F M Severijnen, Dieter Edbauer, Alex Maas, Nicolas Charlet-Berguerand, Rob Willemsen, John C van Swieten

Affiliations

  1. Department of Clinical Genetics, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. [email protected].
  2. , PO Box 2040, 3000 CA, Rotterdam, The Netherlands. [email protected].
  3. Department of Clinical Genetics, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands.
  4. Department of Neurology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands.
  5. German Center for Neurodegenerative Diseases, 81337, Munich, Germany.
  6. Department of Cell Biology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands.
  7. Department of Neurobiology and Genetics, IGBMC, INSERM U964, CNRS UMR7104, University of Strasbourg, Illkirch, France.
  8. Department of Neurology, Neuroscience Campus Amsterdam, 1007 MB, Amsterdam, The Netherlands.

PMID: 27938413 PMCID: PMC5148842 DOI: 10.1186/s40478-016-0401-9

[No abstract available.]

References

  1. Acta Neuropathol Commun. 2014 Dec 13;2:166 - PubMed

Publication Types